This leads to the effect in which the upregulation of MCL1 in these cancers not only suppresses the traditional Bcl-2 family regulation of apoptosis, but also suppresses the specific upregulation of TP73 and the resulting anti-tumor effects of these platinum-based compounds. This evidence concerns the gene MCL1 and neoplasm.